Immuneering (IMRX) Other Non-Current Assets: 2020-2024
Historic Other Non-Current Assets for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to $1.3 million.
- Immuneering's Other Non-Current Assets rose 74.23% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.3 million, marking a year-over-year increase of 74.23%. This contributed to the annual value of $1.0 million for FY2023, which is 39.09% up from last year.
- Latest data reveals that Immuneering reported Other Non-Current Assets of $1.3 million as of Q3 2024, which was up 5.51% from $1.2 million recorded in Q2 2024.
- In the past 5 years, Immuneering's Other Non-Current Assets ranged from a high of $1.3 million in Q3 2024 and a low of $14,333 during Q4 2020.
- Over the past 3 years, Immuneering's median Other Non-Current Assets value was $743,703 (recorded in 2023), while the average stood at $788,069.
- Over the last 5 years, Immuneering's Other Non-Current Assets had its largest YoY gain of 5,044.02% in 2022, and its largest YoY loss of 90.67% in 2022.
- Immuneering's Other Non-Current Assets (Quarterly) stood at $14,333 in 2020, then surged by 612.54% to $102,129 in 2021, then skyrocketed by 628.20% to $743,703 in 2022, then soared by 39.09% to $1.0 million in 2023, then surged by 74.23% to $1.3 million in 2024.
- Its Other Non-Current Assets was $1.3 million in Q3 2024, compared to $1.2 million in Q2 2024 and $1.2 million in Q1 2024.